Spasmoil™

Natural spasmolytic with essential peppermint and fennel oils, for the immediate treatment of Irritable Bowel Syndrome (IBS) symptoms.

Code:

4751020310988

Packaging:

Eco pack containing 30 soft clear capsules.

The efficacy of its composition is proven by a significant number of clinical studies on the effects of the two active ingredients of Spasmoil on IBS.

Its unique combination also treats the D-IBS (diarrhea) and C-IBS (constipation) variations. It does not effect the frequency of bowel movements.

Targeted action against IBS symptoms in both the small and large intestine.

Description

Natural spasmolytic of clinically proven efficacy. The benefits for patients suffering from Irritable Bowel Syndrome who use Spasmoil are unique. Spasmoil is a natural spasmolytic containing high quality essential oils – peppermint and fennel oils – and offers immediate relief from spasms and pain. The active ingredients of peppermint – mentol-1 and methyl salicylate – have a spasmolytic action on the smooth intestinal muscles of the small and large intestine.

The essential fennel oil helps relax the smooth muscles of the entire intestinal tract, advancing the release of gas. A safe preventive measure compared to synthetic equivalents. Reliable, effective long-term use for abdominal pain and bloating, based on natural ingredients.

Spasmoil was created to alleviate the painful abdominal spasms caused by IBS.

Available in physical and online pharmacies.

Composition

Essential oil from peppermint (Μenta piperata) leaves, 200mg.

Essential oil from fennel (Foeniculum vulgare) seeds, 20mg.

Dosage – Instructions for Administration

Dose-dependent intake of a soft capsule 1 to 3 times a day, depending on the severity of the symptoms and doctor’s recommendation.

To be taken with a large glass of water 1 hour before meal. Swallow, do not chew.

Food supplement. Food supplements should not be used instead of a balanced diet.

Do not exceed the recommended daily dosage.

Restrictions on use in case of high sensitivity (allergy) to any of the product ingredients. This product is not intended for the prevention or treatment of a human disease.

Keep out of the reach of children.

References

Hills, J. M. & Aaronson, P. I. The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. Gastroenterology 101, 55–65 (1991)

Galeotti, N., Di Cesare Mannelli, L., Mazzanti, G., Bartolini, A. & Ghelardini, C. Menthol: a natural analgesic compound. Neurosci. Lett. 322, 145–148 (2002)

Juergens, U. R., Stober, M. & Vetter, H. The antiin. ammatoryactivity of L- menthol compared to mintoil in human monocytes in vitro: a novel perspective for its therapeutic use in in. ammatory diseases. Eur. J. Med. Res. 3, 539–545 (1998)

Walstab, J. et al. Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors:implications for treating gastrointestinal disorders. Neurogastroenterol Motil. 26, 810–820 (2014) Liu, B. et al. TRPM8 is the principal mediator of mentholinduced analgesia of acute and in. ammatorypain. Pain 154, 2169–2177 (2013)

¹P. Chumpitazi. Review article: the physiological e. ects and safety of peppermint oil and its e. cacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018;47:738–752

Shamkant B. Badgujar. Foeniculum vulgare Mill: A Review of Its Botany, Phytochemistry, Pharmacology, Contemporary Application, and Toxicology. Biomed Res Int. 2014: 842674 (2014)

Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol 2014;48:505–12.

Certifications

National Organization for Medicines (EOF) of Greece (EOF Notification No.: 127080/24-10-2019), FDA, GMP, ACG, WGO